Harold D. Tamayo

About Harold D. Tamayo

I build and scale healthcare platforms by aligning finance, operations, and technology to drive performance. As a CFO and Board Director with 20+ years across biopharma, medtech, pharmacy, and healthcare services, I have led organizations through complex operating environments including IPO readiness, private equity ownership, M&A integration, and multi-region expansion. My role consistently extends beyond finance into operational execution, infrastructure buildout, and performance management. I have operated across public, PE-backed, and privately held companies, leading multi-business unit platforms where success requires tight coordination across commercial, supply chain, and financial functions. This includes building scalable operating models, improving visibility into unit economics, and driving accountability across the organization. My background includes leadership roles at Merck, Novartis, Express Scripts, CVS Omnicare, and McKesson, as well as scaling growth-stage companies where speed, discipline, and execution matter. I am most effective in environments that require structure without slowing growth. I operate across the full enterprise including P&L performance, balance sheet discipline, and cash flow generation, with direct ownership of capital allocation, liquidity, and operating outcomes. My experience includes driving revenue growth, expanding EBITDA, improving cash conversion, and implementing the infrastructure needed to support scale. Currently, I serve as CFO of CareTria, where I am helping scale a multi-business unit healthcare services platform across patient access, distribution, and technology-enabled solutions.

Experience

1. Chief Financial Officer

   CareTria

   Oct 2025 — Present · Somerset, NJ, US

   Private Equity (PE) owned organization by Frazier Healthcare Partners formerly (Knipper Health). Responsible for the overall financial leadership, governance, and strategic direction of the combined company. Core responsibilities include: Financial Strategy & Planning – Lead financial forecasting, long-range planning, capital structure optimization, and integration of Knipper Health’s commercialization services with eBlu’s specialty patient support platform. Capital Markets & Investor Relations – Partner with private equity sponsors (Frazier) and the board to manage equity, debt, M&A financing, and investor communications. Accounting & Compliance – Oversee controllership, audit, tax, and SOX-readiness standards; ensure proper revenue recognition across HUB services, copay programs, distribution, and technology platforms. Operational Finance & Integration – Drive synergies between Knipper and eBlu (ERP, financial systems, shared services), optimize margin performance, and align cost structures post-acquisition. Corporate Development – Support strategic acquisitions and partnerships in pharma services and patient access, performing due diligence, valuation, and integration planning. Executive Leadership – Serve as a key member of the executive team, advising the CEO and board on growth initiatives, risk management, and shareholder value creation.

Education

• MIT Sloan School of Management

  Executive Program, Developing a Product Technology Strategy

• Indiana University - Kelley School of Business

  Post MBA, Accounting and Finance

• Florida International University - College of Engineering & Computing

  Bachelor of Engineering - BE, Electrical/Biomedical

• University of Miami

  Dual Masters: MBA | MSc Industrial Engineering, Finance | Operations Management